新冠疫情中用途广泛的肝素。 - Suppr

Suppr

超能文献

The versatile heparin in COVID-19.

作者信息

Thachil Jecko

机构信息

Department of Haematology, Manchester University Hospitals, Manchester, UK.

出版信息

J Thromb Haemost. 2020 May;18(5):1020-1022. doi: 10.1111/jth.14821. Epub 2020 Apr 27.

DOI:10.1111/jth.14821

PMID:32239799

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9906146/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7275/9906146/9556f6eb4e57/jth14821-fig-0001-m_lrg.jpg

相似文献

The versatile heparin in COVID-19.新冠疫情中用途广泛的肝素。

J Thromb Haemost. 2020 May;18(5):1020-1022. doi: 10.1111/jth.14821. Epub 2020 Apr 27.

Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients.肝素在治疗新冠肺炎患者中的抗凝和抗心律失常作用。

J Thromb Haemost. 2020 Aug;18(8):2073-2075. doi: 10.1111/jth.14902.

Potential of heparin and nafamostat combination therapy for COVID-19.肝素与那法莫司他联合治疗新冠肺炎的潜力

J Thromb Haemost. 2020 Jun;18(6):1521-1522. doi: 10.1111/jth.14858. Epub 2020 May 6.

Differentiating biochemical from clinical heparin resistance in COVID-19.区分COVID-19中生化性与临床性肝素抵抗

J Thromb Thrombolysis. 2020 Nov;50(4):1015-1016. doi: 10.1007/s11239-020-02259-5.

Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care.肝素失效与新冠病毒病：我们是否应探索其他抗凝剂？一份关于重症监护病房新冠病毒病患者抗凝作用体外恢复情况的观察报告

Thromb Res. 2020 Nov;195:226-227. doi: 10.1016/j.thromres.2020.08.010. Epub 2020 Aug 9.

Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?新冠病毒感染中的肺栓塞或肺血栓形成？使用高剂量肝素进行血栓预防的建议是否合理？

Thromb Haemost. 2020 Aug;120(8):1230-1232. doi: 10.1055/s-0040-1712097. Epub 2020 Apr 29.

Pulmonary embolism in patients with COVID-19 and its treatment based on low-molecular-weight heparin.新型冠状病毒肺炎患者的肺栓塞及其基于低分子量肝素的治疗

Sao Paulo Med J. 2020 Jul-Aug;138(4):349-351. doi: 10.1590/1516-3180.2020.0221.r2.22072020.

Type and dose of heparin in Covid-19: Reply.新冠病毒病中肝素的类型和剂量：回复

J Thromb Haemost. 2020 Aug;18(8):2063-2064. doi: 10.1111/jth.14870. Epub 2020 May 11.

Reply to Rheumatologists' perspective on coronavirus disease 19: is heparin the dark horse for COVID-19?对风湿病学家关于冠状病毒病19的观点的回应：肝素会是治疗COVID-19的黑马吗？

Clin Rheumatol. 2020 Jul;39(7):2099-2100. doi: 10.1007/s10067-020-05145-w. Epub 2020 May 9.

Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy.接受肝素治疗的COVID-19患者中抗肝素-PF4复合物抗体的检测。

Blood Transfus. 2020 Jul;18(4):328. doi: 10.2450/2020.0164-20.

引用本文的文献

Multifaceted Heparin: Diverse Applications beyond Anticoagulant Therapy.多面肝素：抗凝治疗之外的多样应用

Pharmaceuticals (Basel). 2024 Oct 12;17(10):1362. doi: 10.3390/ph17101362.

Management of Therapeutic-intensity Unfractionated Heparin: A Narrative Review on Critical Points.治疗强度普通肝素的管理：关键点的叙述性综述

TH Open. 2024 Oct 17;8(3):e297-e307. doi: 10.1055/a-2359-0987. eCollection 2024 Jul.

Controversies in COVID-19: Diagnostic Evaluation and Management in Neuro-COVID.新冠病毒的争议点：神经新冠中的诊断评估与管理。

Adv Exp Med Biol. 2024;1457:185-197. doi: 10.1007/978-3-031-61939-7_10.

Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia.新型冠状病毒肺炎危重症患者普通肝素治疗的治疗窗时间

Ther Clin Risk Manag. 2024 Sep 10;20:611-618. doi: 10.2147/TCRM.S476187. eCollection 2024.

Venous Thromboembolism Management throughout the COVID-19 Era: Addressing Acute and Long-Term Challenges.COVID-19 疫情期间的静脉血栓栓塞症管理：应对急性和长期挑战

J Clin Med. 2024 Mar 21;13(6):1825. doi: 10.3390/jcm13061825.

COVID-19-Associated Portal Vein Thrombosis Post-Cholecystitis.胆囊炎后与 COVID-19 相关的门静脉血栓形成

Int J Angiol. 2022 May 24;32(4):262-268. doi: 10.1055/s-0042-1743409. eCollection 2023 Dec.

COVID-19 Associated Micro-Anastomotic Thrombosis After Abdominal Free Tissue Transfer: A Case Report and Literature Review.腹部游离组织移植术后与 COVID-19 相关的微小吻合口血栓形成：一例报告及文献综述

Plast Surg (Oakv). 2023 Nov;31(4):408-412. doi: 10.1177/22925503231161081. Epub 2023 Mar 14.

Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials.低分子量肝素预防重症非危重型 COVID-19 患者临床恶化的效果：两项随机对照试验的联合分析。

Intern Emerg Med. 2024 Jan;19(1):71-79. doi: 10.1007/s11739-023-03439-w. Epub 2023 Oct 4.

Non-Anticoagulant Activities of Low Molecular Weight Heparins-A Review.低分子量肝素的非抗凝血活性——综述

Pharmaceuticals (Basel). 2023 Sep 5;16(9):1254. doi: 10.3390/ph16091254.

Pathological Effects of SARS-CoV-2 Associated with Hematological Abnormalities.与血液学异常相关的新型冠状病毒2型（SARS-CoV-2）的病理效应

Curr Issues Mol Biol. 2023 Aug 28;45(9):7161-7182. doi: 10.3390/cimb45090453.

本文引用的文献

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。

J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.

Coronaviruses and the cardiovascular system: acute and long-term implications.冠状病毒与心血管系统：急性和长期影响

Eur Heart J. 2020 May 14;41(19):1798-1800. doi: 10.1093/eurheartj/ehaa231.

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。

J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.

Effects of nebulized antithrombin and heparin on inflammatory and coagulation alterations in an acute lung injury model in rats.雾化抗凝酶和肝素对大鼠急性肺损伤模型中炎症和凝血改变的影响。

J Thromb Haemost. 2020 Mar;18(3):571-583. doi: 10.1111/jth.14685. Epub 2019 Dec 16.

Unfractionated heparin attenuates histone-mediated cytotoxicity in vitro and prevents intestinal microcirculatory dysfunction in histone-infused rats.未分级肝素可减轻体外组蛋白介导的细胞毒性，并预防组蛋白输注大鼠的肠道微循环功能障碍。

J Trauma Acute Care Surg. 2019 Sep;87(3):614-622. doi: 10.1097/TA.0000000000002387.

Unfractionated Heparin Alleviates Sepsis-Induced Acute Lung Injury by Protecting Tight Junctions.未分级肝素通过保护紧密连接缓解脓毒症诱导的急性肺损伤。

J Surg Res. 2019 Jun;238:175-185. doi: 10.1016/j.jss.2019.01.020. Epub 2019 Feb 13.

New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey.基于修订后的脓毒症定义的脓毒症诱导凝血功能障碍（SIC）新标准：一项全国性调查的回顾性分析

BMJ Open. 2017 Sep 27;7(9):e017046. doi: 10.1136/bmjopen-2017-017046.

Heparin prevents Zika virus induced-cytopathic effects in human neural progenitor cells.肝素可预防寨卡病毒对人类神经祖细胞产生的细胞病变效应。

Antiviral Res. 2017 Apr;140:13-17. doi: 10.1016/j.antiviral.2016.12.023. Epub 2017 Jan 5.

More than an anticoagulant: Do heparins have direct anti-inflammatory effects?不仅仅是一种抗凝剂：肝素是否具有直接抗炎作用？

Thromb Haemost. 2017 Feb 28;117(3):437-444. doi: 10.1160/TH16-08-0620. Epub 2016 Dec 15.

Failure of chemical thromboprophylaxis in critically ill medical and surgical patients with sepsis.脓毒症的危重症内科和外科患者化学性血栓预防失败

J Crit Care. 2017 Feb;37:206-210. doi: 10.1016/j.jcrc.2016.10.002. Epub 2016 Oct 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验